A comparative study on the healing effects of rebamipide and omeprazole in Helicobacter pylori-positive gastric ulcer after eradication therapy

Trial Profile

A comparative study on the healing effects of rebamipide and omeprazole in Helicobacter pylori-positive gastric ulcer after eradication therapy

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Sep 2016

At a glance

  • Drugs Rebamipide (Primary) ; Omeprazole
  • Indications Gastric ulcer
  • Focus Therapeutic Use
  • Sponsors Otsuka Pharmaceutical
  • Most Recent Events

    • 22 Dec 2009 Actual end date (Apr 2008) and actual patient number (132) added as reported by ClinicalTrials.gov.
    • 21 Jul 2007 Status changed from recruiting to completed.
    • 06 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top